Skip to main content Back to Top


Ciprofloxacin Ophthalmic Solution

Products Affected - Description

    • Ciprofloxacin ophthalmic solution, Akorn, 0.3%, 2.5 mL bottle, NDC 17478-0714-25
    • Ciprofloxacin ophthalmic solution, Akorn, 0.3%, 5 mL bottle, NDC 17478-0714-10

Reason for the Shortage

    • Akorn did not provide a reason for the shortage.
    • Novartis has Ciloxan available.
    • Sandoz has ciprofloxacin ophthalmic solution available.

Available Products

    • Ciloxan ophthalmic solution, Novartis, 0.3%, 5 mL bottle, NDC 00065-0656-05
    • Ciprofloxacin ophthalmic solution, Sandoz, 0.3%, 10 mL bottle, NDC 61314-0656-10
    • Ciprofloxacin ophthalmic solution, Sandoz, 0.3%, 2.5 mL bottle, NDC 61314-0656-25
    • Ciprofloxacin ophthalmic solution, Sandoz, 0.3%, 5 mL bottle, NDC 61314-0656-05

Estimated Resupply Dates

    • Akorn has ciprofloxacin ophthalmic solution on back order and the company cannot estimate a release date.


Updated September 24, 2019 by Rachael Freeman, PharmD, BCPS. Created July 17, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins